Dear Thomas,

for me the link to the doodle is currently not working.

Any idea what might be wrong ?

Best regards,

Ivo


On 20/04/2011 10:30, Thomas Giger wrote:

Dear All,

I have added more days in the first week of May (3-6) for scheduling the TC.

Can I ask you to update the data that you have already entered in the doodle?

Could you please fill in the doodle by Monday (April 25)?

here's the link: http://doodle.com/cnfc85cx9ushxzyb

cheers,

Thomas

On Apr 19, 2011, at 12:31 PM, Emmanouil Dermitzakis wrote:

Hi Ivo and all

I agree!

We have to do this soon though so I will ask Thomas to add more dates the week after but we should not slide beyond it.

Cheers

Manolis

MD

Sent from my iPhone

Please excuse typos/brevity

On Apr 19, 2011, at 11:36 AM, Ivo Gut <igut@pcb.ub.es> wrote:

Dear All,

unfortunately for you, I am on holidays next week. I was in the call yesterday and I think it is critical that we nail this experiment down absolutely right, otherwise we will certainly fail. This experiment is too expensive for us to fail !!!

Any chance of suggesting other dates ?

With best regards,

Ivo


On 19/04/2011 10:42, Thomas Giger wrote:

Dear All,

As we decided yesterday, the people involved in the RNAseq related part of the experiment should have a conference call to discuss open questions.

I have written down the following points that should be discussed:

1. As of now we made plans that the different labs analyze samples from one particular population (as listed in the workflow document that I've sent around on April 7).

It would be a better experimental design if the samples were randomly distributed among the different labs. Since there is still time to react - do we want to switch the strategy?

2. How long are the library prep / sequencer queue up times in the different labs (once you receive the RNA samples - how long do you think will it take you to analyze them?).

If some labs expect to have much larger delays, we could make arrangements that those labs get samples earlier than other labs. 

This would also mean that we would all use the protocol that is used at the time point when the first lab starts to analyze samples.

3. Which other samples (other than the 500 1KGP European samples) should be analyzed by RNAseq? 

4. Specifications for the small RNA protocol.

If you know already now, that you would like to have additional things discussed - please let me know and I can make sure that we don't forget about.

We would like to schedule the call for either next Tuesday (April 26) or Wednesday (April 27). 

Please fill in the doodle by the end of this week so that we can select a time where a maximum number of people can attend the call: http://doodle.com/cnfc85cx9ushxzyb

cheers,

Thomas

------------------------------------------------------------------------

Thomas Giger, Ph.D.

Department of Genetic Medicine and Development

University of Geneva Medical School

1 Rue Michel-Servet

Geneva 1211

Switzerland

_______________________________________________
Geuvadis_rnaseq mailing list
Geuvadis_rnaseq@lists.crg.es
http://davinci.crg.es/mailman/listinfo/geuvadis_rnaseq

_______________________________________________
Geuvadis_rnaseq mailing list
Geuvadis_rnaseq@lists.crg.es
http://davinci.crg.es/mailman/listinfo/geuvadis_rnaseq

_______________________________________________
Geuvadis_rnaseq mailing list
Geuvadis_rnaseq@lists.crg.es
http://davinci.crg.es/mailman/listinfo/geuvadis_rnaseq

------------------------------------------------------------------------

Thomas Giger, Ph.D.

Department of Genetic Medicine and Development

University of Geneva Medical School

1 Rue Michel-Servet

Geneva 1211

Switzerland

_______________________________________________
Geuvadis_rnaseq mailing list
Geuvadis_rnaseq@lists.crg.es
http://davinci.crg.es/mailman/listinfo/geuvadis_rnaseq